LBRX (LB Pharmaceuticals, Inc.) Net earnings per one share for the last twelve months

LB Pharma (LBRX) - corporate logo

The price chart for LB Pharmaceuticals Inc (LBRX) on the GURU.Markets platform demonstrates a value of -485.50. This price action reflects the performance of stable management focused on psychopharmacological research and the successful completion of clinical trials. LB Pharmaceuticals Inc (LBRX) possesses market power due to the development of a modified amisulpride with minimal side effects. Patent protection for innovative schizophrenia therapy methods allows the firm to maintain pricing power and set premium prices for its drugs.

lbpharma.us (LBRX) Net earnings per share (EPS TTM): for the period 11/23/2025 - 11/16/2026

LBRX (LB Pharmaceuticals Inc): analytical breakdowns and indicator data

- market price and analyst price targets:
- business market valuation indicators:
Fundamental company valuation:LB Pharma - LBRX
Core merchandise of LB Corp

For LB Pharmaceuticals Inc (LBRX), the earnings per share trend reflects the efficiency of investments in psychopharmaceutical development and the modernization of IT screening. This metric measures the percentage change in net income over the last twelve months relative to the previous year, revealing the actual pace of capitalization. By analyzing the annual EPS TTM YoY trend, an investor can eliminate reporting lags and uncover hidden operational risks. Steady growth in this metric confirms the viability of the outsourcing model for test batch production.